http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 최여옥 (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
발효산삼배양근농축액의 산화방지 효과 및 과산화수소로 유발된 PC12 세포독성 보호효과
최여옥(Yeo Ok Choi),김유리(Yu-Ri Kim),신승용(Seung-Yong Shin),이재근(Jae Geun Lee),김철중(Chul Joong Kim),이예지(Ye ji Lee),강병주(Byeongju Kang),김관수(Gwansu Kim),최지은(Jee Eun Choi),한범석(Beom-Seok Han) 한국식품과학회 2018 한국식품과학회지 Vol.50 No.4
대부분의 신경퇴행성질환은 산화스트레스의 영향을 받는다. 따라서 본 연구에서는 진세노사이드 Rg5와 Rk1을 함유하고 있는 발효산삼배양근 농축액인 HLJG0701의 산화방지 효능을 확인하였다. 그 결과, HLJG0701는 효과적인 DPPH와 ABTS 라디칼제거능을 나타냈으며(IC<SUB>50</SUB>: 16배, 4배 희석액), 황산철(II) 유도군의 지방질 과산화물 발생 비교 시, 용량의존적으로 억제됨을 확인하였다(8배 희석액: 2.3 nM, 4배 희석액: 1.5 nM). HLJG0701의 세포 보호 효과를 MTT, LDH 분석으로 평가한 결과, 8, 16, 32, 64배 희석액의 HLJG0701를 처리한 경우 70, 53, 35, 26%의 세포생존율이 증가됨을 확인하였다. LDH 방출 측정 결과, H₂O₂로 인해 3.6배까지 증가한 LDH 활성은 8배 희석액의 HLJG0701 처리시 1.3배 수준까지 감소하였다. 또한 HLJG0701가 PC12세포에 발생한 산화스트레스 DCF-DA 분석(16배 희석액: 50% ROS 억제, 4배 희석액: 68% ROS 억제), TBARS (16배 희석액: 50.7% 감소, 4배 희석액: 46.5% 감소), GPx (16배 희석액: 133.3% 증가, 4배 희석액: 227.3% 증가), 그리고 SOD (16배 희석액: 118.2% 증가, 4배 희석액: 218.2% 증가) 분석으로 확인하였다. 위 결과는 HLJG0701가 산화방지 효능을 매개로 신경세포를 보호함으로써 신경퇴행성질환을 예방할 수 있는 가능성 있는 후보물질이 될 수 있다는 것을 의미하며, 임상시험 등 다양한 연구가 충분하지 않은 상태이므로 앞으로 지속적인 연구가 필요할 것으로 사료된다. Most neurodegenerative diseases are known to be influenced by oxidative stress. We investigated the antioxidative activity of the concentrate of fermented wild ginseng root culture (HLJG0701) containing ginsenosides Rg5 and Rk1. HLJG0701 showed effective DPPH and ABTS radical scavenging ability (IC<SUB>50</SUB>: 16- and 4-fold dilution, respectively) and was inhibited dose-dependently by the FeSO₄-induced lipid peroxidation group (8- and 4-fold dilution: 2.3 and 1.5 nM, respectively). In MTT and LDH assays, 8-, 16-, 32- and 64-fold diluted HLJG0701 significantly increased cell viability by 70, 53, 35, and 26%, respectively. LDH released by HLJG0701 was reduced 1.3-fold with 8-fold diluted HLJG0701 compared to the H₂O₂-treated control. In addition, the inhibitory effect of HLJG0701 on oxidative stress in PC12 cells was confirmed by DCF-DA analysis (16-, 4-fold diluted HLJG0701: 50 and 68% ROS inhibition, respectively), TBARS (16- and 4-fold diluted HLJG0701: 50.7 and 46.5% inhibition, respectively), GPx (16- and 4-fold diluted HLJG0701: 133.3 and 227.3% release, respectively), and SOD analysis (16- and 4-fold diluted HLJG0701: 118.2 and 218.2% release, respectively). These results suggested that HLJG0701 protects neuronal cells by its anti-oxidative effects and hence can be a potential preventive material against neurodegenerative diseases.
-
L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine
Begum Akuzum,김시내,Tam Thanh Nguyen,홍재우,이시영,김은혜,김주희,최여옥,전현정,이영민,김현우,손동현,김수현 대한면역학회 2018 Immune Network Vol.18 No.3
Virus-like particles (VLPs) derived from human papillomavirus (HPV) L1 capsid proteins were used for HPV quadrivalent recombinant vaccine. The HPV quadrivalent vaccine is administrated in a 3-dose regimen of initial injection followed by subsequent doses at 2 and 6 months to prevent cervical cancer, vulvar, and vaginal cancers. The type 6, 11, 16, or 18 of HPV infection is associated with precancerous lesions and genital warts in adolescents and young women. The HPV vaccine is composed of viral L1 capsid proteins are produced in eukaryotic expression systems and purified in the form of VLPs. Four different the L1 protein of 3 different subtypes of HPV: HPV11, HPV16, and HPV18 were expressed in Escherichia coli divided into 2 fragments as N- and C-terminal of each protein in order to examine the efficacy of HPV vaccine. Vaccinated sera failed to recognize N-terminal L1 HPV type 16 and type 18 by western blot while they detected N-terminal L1 protein of HPV type 11. Moreover, the recombinant C-terminal L1 proteins of type 16 was non-specifically recognized by the secondary antibody conjugated with horseradish peroxidase. This expression and purification system may provide simple method to obtain robust recombinant L1 protein of HPV subtypes to improve biochemical analysis of antigens with immunized sera.
ScienceON
DBpia연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
